Cabaletta Bio, Inc. (CABA) Insider Trading -- Recent Executive & Director Transactions
8 insiders reported 8 Form 4 transactions for Cabaletta Bio, Inc. (CABA) over the past 18 months (most recent 2026-01-21). Recent activity: Tomasello Shawn (Director) Buy 22,725 shares, Bollard Catherine (Director) Buy 4,405 shares, Simon Mark (Director) Buy 11,061 shares, Gerard Michael (General Counsel) Buy 6,600 shares, Chang David J. (Chief Medical Officer) Buy 8,800 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-21 | Tomasello Shawn | Director | Buy | 22,725 | $50,222 |
| 2026-01-21 | Bollard Catherine | Director | Buy | 4,405 | $9,999 |
| 2026-01-21 | Simon Mark | Director | Buy | 11,061 | $25,219 |
| 2026-01-21 | Gerard Michael | General Counsel | Buy | 6,600 | $14,982 |
| 2026-01-21 | Chang David J. | Chief Medical Officer | Buy | 8,800 | $19,888 |
| 2026-01-21 | Nichtberger Steven | President & CEO | Buy | 45,000 | $100,800 |
| 2026-01-21 | Gavel Steve | Chief Commercial Officer | Buy | 22,170 | $50,326 |
| 2026-01-21 | Binder Gwendolyn | President, Science & Tech. | Buy | 11,312 | $24,773 |
Source: SEC Form 4 filings · as of 2026-01-21